Southeastern Pennsylvania Life Sciences Impact Summit

1
Southeastern Pennsylvania Life Sciences Impact
Summit June 8, 2009
2
The Bioscience Continuum in Greater Philadelphia
Commercialization BioAdvance Ben Franklin
Technology Partners
Emerging Industry Biotech, Device,
Diagnostic Avid Garnet BioTherapeutics Melior
Discover NuPathe TengionTetraLogic Yaupon And
more
Early-stage risk capital Pre-seed/seed funding
Basic research funding (i.e. NIH)
World-class Research Drexel Univ. Fox
Chase Temple University Thomas Jefferson
Univ. Univ. of Pennsylvania Wistar Institute And
More
VC funding
Mature Industry Biotech, Device, Diagnostic
Business Climate, business support tax policy,
access to bio-pharmaceuticals, etc.
Adolor Centocor Fujirebio MedImmune ViroPharma An
d more
Global Bio-pharmaceuticals AstraZeneca
Cephalon Merck
GlaxoSmithKline Johnson Johnson
Sanofi-Aventis Shire
Wyeth
3
Bringing a Therapeutic to Market

• 10-15 years
• More than 800 million
• Rigorous regulatory review
• Post-marketing studies and surveillance

4
Source Centers for Medicare and Medicaid Services
5
(No Transcript)
6
Life Sciences Company Cluster
7
Academic Institutions Cluster
8
Early-stage Capitalists
9
(No Transcript)
10
Southeastern PA Life Sciences Company Cluster
County rankings by employment
Rank County of establishments of
workers 1 Montgomery County 127 24,745
2 Chester County 72 7,692 3
Philadelphia County 79 2,845 4 Bucks
County 91 2,172 5 Delaware County 33
785 Total 402 38,239
11

• For more information on todays discussion,
• The Greater Philadelphia Life Sciences Cluster
  study or
• We Work For Health, please visit
• www.weworkforhealth.org/pennsylvania